The effect of physician prescribing patterns based on ESC guidelines on morbidity improvement among heart failure patients
Abstract
Keywords
Full Text:
PDFReferences
Berliner, D., & Bauersachs, J. (2017). Current drug therapy in chronic heart failure - the new guidelines of the european society of cardiology (ESC). Korean Circulation Journal, 47(5), 543–554. https://doi.org/10.4070/kcj.2017.0030
Bratsos, S. (2019). Efficacy of angiotensin converting enzyme inhibitors and angiotensin receptor-neprilysin inhibitors in the treatment of chronic heart failure: a review of landmark trials. Cureus, 11(1), 1–8. https://doi.org/10.7759/cureus.3913
Brink, E., Persson, L. O., & Karlson, B. W. (2009). Coping with myocardial infarction: Evaluation of a coping questionnaire. Scandinavian Journal of Caring Sciences, 23(4), 792–800. https://doi.org/10.1111/j.1471-6712.2008.00666.x
Burnett, H., Earley, A., Voors, A. A., Senni, M., McMurray, J. J. V., Deschaseaux, C., & Cope, S. (2017). Thirty years of evidence on the efficacy of drug treatments for chronic heart failure with reduced ejection fraction: a network meta-analysis. Circulation Heart Failure, 10, 1–13. https://doi.org/10.1161/CIRCHEARTFAILURE.116.003529
Kehat, I., & Molkentin, J. D. (2010). Molecular pathways underlying cardiac remodeling during pathophysiologic stimulation. Circulation, 122(25), 2727–2735. https://doi.org/10.1161/CIRCULATIONAHA.110.956839
Lee, D. S., Gona, P., Vasan, R. S., Larson, M. G., Benjamin, E. J., Wang, T. J., Tu, J. V., & Levy, D. (2009). Relation of disease etiology and risk factors to heart failure with preserved or reduced ejection fraction: insights from the national heart, lung, and blood institutes’s framingham heart study. Circulation, 119(24), 3070–3077. https://doi.org/10.1161/CIRCULATIONAHA.108.815944.RELATION
Majid, A. (2010). Factors analysis felated to readmission on patient with congestive heart failure in Yogyakarta Hospital year 2010. University of Indonesia.
Martin, N., Manoharan, K., Thomas, J., Davies, C., & Lumbers, R. T. (2018). Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction. Cochrane Database of Systematic Reviews, 2018(6), 1–197. https://doi.org/10.1002/14651858.CD012721.pub2
Mcmurray, J. J. V, Adamopoulos, S., Anker, S. D., Auricchio, A., Bohm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., Gomez-Sanchez, M. A., Jaarsma, T., Køber, L., Lip, G. Y. H. ., Maggioni, A. Pietro, Parkhomenko, A., Pieske, B. M., Popescu, B. A., Rønnevik, P. K., Rutten, F. H., … Zeiher, A. (2012). ESC Guideines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. European Heart Journal, 33, 1787–1847. https://doi.org/10.1093/eurheartj/ehs104
Ogbemudia, E. J., & Asekhame, J. (2016). Rehospitalization for heart failure in the elderly. Saudi Medical Journal, 37(10), 1144–1147. https://doi.org/10.15537/smj.2016.10.15259
Oshikoya, K. A., Senbanjo, I. O., & Amole, O. O. (2009). Interns’ knowledge of clinical pharmacology and therapeutics after undergraduate and on-going internship training in Nigeria: a pilot study. BMC Medical Education, 9(50), 1–9. https://doi.org/10.1186/1472-6920-9-50
Parker, R. B., Rodgers, J. E., & Cavallari, L. H. (2008). Pharmacotherapy a pathophysiologic approach. In J. T. Dipiro, R. L. Talbert, G. C. Yee, G. R. Matzke, B. G. Wells, & L. M. Posey (Eds.), Pharmacotherapy A Pathophysiologic Approach (7th ed., pp. 173–212). The McGraw-Hill Companies, Inc. https://doi.org/10.1036/007147899X
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., Gonzalez-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J. T., Pieske, B., Riley, J. P., Rosano, G. M. C., Ruilope, L. M., Ruschitzka, F., … Meer, P. van der. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). European Heart Journal, 1–85. https://doi.org/10.1093/eurheartj/ehw128
Rascati, K. (2014). Essentials of pharmacoeconomics (2nd ed.). Lippincott Williams & Wilkins.
Syahidah, H. (2017). Kualitas hidup pasien kanker yang menjalani kemoterapi di RSI Sultan Agung Semarang. Universitas Muhammadiyah.
Tangsatitkiat, W., & Sakthong, P. (2010). Thai version of the minnesota living with heart failure questionnaire: psychometric testing using a longitudinal design. Asian Biomedicine, 4(6), 877–884. https://doi.org/10.2478/abm-2010-0115
Teng, T. K., Tromp, J., Tay, W. T., Anand, I., Ouwerkerk, W., Chopra, V., Wander, G. S., Yap, J. J. L., MacDonald, M. R., Xu, C. F., Chia, Y. M., Shimizu, W., Richards, A. M., Voors, A., & Lam, C. S. (2018). Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study. The Lancet Global Health, 6, e1008–e1018. https://doi.org/10.1016/S2214-109X(18)30306-1
Upadhya, B., & Kitzman, D. W. (2017). Heart failure with preserved ejection fraction in older adult. Heart Failure Clinics, 13(3), 485–502. https://doi.org/10.1016/j.hfc.2017.02.005
WHO. (2007). Prevention of cardiovascular disease: pocket guidelines for assessment and management of cardiovascular risk. In World Health Organization. WHO Press.
WHO. (2020). Cardiovascular Diseases. World Health Organization.
Yaghoubi, A., Tabrizi, J., Mirinazhad, M., Azami, S., Naghavi-behzad, M., & Ghojazadeh, M. (2012). Quality of life in cardiovascular patients in Iran and factors affecting It: a systematic Review. Journal of Cardiovascular and Thoracic Research, 4(4), 95–101. https://doi.org/10.5681/jcvtr.2012.024
DOI: http://dx.doi.org/10.12928/pharmaciana.v11i1.16730
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Ema Pristi Yunita
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Office: Faculty of Pharmacy, Universitas Ahmad Dahlan
Jl. Prof. Dr. Soepomo, S.H., Janturan, Warungboto, Umbulharjo, Yogyakarta, Indonesia
Kode pos 55164
Email: pharmaciana@pharm.uad.ac.id